Replies to post #213538 on Biotech Values

[genisi]

TEVA’s new CEO is Lundbeck’s Kare Schultz

He looks a bit pinkish to relocate to Israel :)

[Bickema]

TEVA up 14% pre market.

Schultz had been widely seen as heir apparent at the world’s largest diabetes drugmaker Novo Nordisk but quit in 2015 when Novo’s former CEO said he would stay until 2019.

He became CEO of Lundbeck in May 2015 shortly and the Danish firm’s share price has more than tripled since he took over and returned it to profit by slimming costs.

Lundbeck is down 12% on new of his departure